1. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin. Microbiol. Infect. 2020; 26(6), 729-734. doi:10.1016/j.cmi.2020.03.026
2. Zhu N, et al. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 2019; 382 (8), 727–733.
3. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal. J. Hear. Lung Transplant. 2020; 39(5), 405– 407.
4. Johns Hopkins University & Medicine. COVID-19 Map – Johns Hopkins Coronavirus Resource Center. Johns Hopkins Coronavirus Resource Center 1. 2020. Disponible en: https://coronavirus.jhu.edu/map.html. (Accessed: 1st December 2020)
5. The Organization for Economic Cooperation and Development. Flattening the covid- 19 peak : Containment and mitigation policies Flattening the COVID-19 peak : Containment and mitigation policies. 2020; 1-27. Disponible en: https://read.oecd- ilibrary.org/view/?ref=124_124999-yt5ggxirhc&title=Flattening_the_COVID- 19_peak-Containment_and_mitigation_policies. (Accessed: 1st December 2020)
6. Stegeman I, et al. Routine laboratory testing to determine if a patient has COVID- 19. Cochrane Database Syst. Rev. 2020. doi:10.1002/14651858.CD013787
7. Yang Y, et al. Laboratory diagnosis and monitoring the viral shedding of 2019- nCoV infections. The Innovation. 2020;1(3), 2–6.
8. Mak GC, et al. Evaluation of rapid antigen test for detection of SARS CoV-2 virus. J. Clin. Virol. 2020. 129 (104500), 1-4.
9. Corman VM, et al. Comparison of seven commercial SARS-CoV-2 rapid Point-of- Care Antigen tests: a single-centre laboratory evaluation study. The Lancet Microbe.2021;5247(21): 1–9. doi:10.1101/2020.11.12.20230292
10. Zhao J, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin. Infect. Dis. 2020; 71(16), 2027-2034doi:10.1093/cid/ciaa344
11. Whitman JD, et al. Test performance evaluation of SARS-CoV-2 serological assays. medRxiv Prepr. Serv. Heal. Sci. 2020; 38(10), 1174–118.
12. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019; 17(3), 181–192.
13. World health organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays Interim guidance, 11 September 2020. World Health Organization (2020). Disponible en: https://apps.who.int/iris/handle/10665/334253.
14. Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 Test Sensitivity — A Strategy for Containment. N. Engl. J. Med. 2020; 383(22). doi:10.1056/nejmp2025631
15. Dinnes J. et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev.2020.
16. World health organization. WHO Emergency use assessment Coronavirus disease (COVID-19) IVDs public report STANDARD Q COVID-19 Ag. 2020. Disponible en: https://www.who.int/diagnostics_laboratory/eual/eul_0563_117_00_standard_q_cov id19_ag_ifu.pdf. (Accesado: 2 de diciembre de 2020)
17. World Health Organization. WHO Emergency use assessment Coronavirus disease (COVID-19) IVDs public report Panbio ABBOTT COVID-19 Ag. 2020. Disponible en: https://www.who.int/diagnostics_laboratory/eual/eul_0564_032_00_panbi_covid19_ ag_rapid_test_device.pdf. (Accessed: 2nd December 2020)
18. Liang Y, et al. Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: Insight into the humoral immunity of SARS. Clin. Chem. 2005. 51(8), 1382–1396.
19. FIND. FIND evaluation of SARS-COV-2 antigen (Ag) detecting tests. 2020. Disponible en: https://www.finddx.org/covid-19/sarscov2-eval-antigen/.
20. Ministerio de Salud de Costa Rica. LS-SS-012. Lineamientos generales para el uso de pruebas de antígeno para diagnóstico de COVID-19. 2020. Disponible en: https://www.ministeriodesalud.go.cr/sobre_ministerio/prensa/docs/ls_ss_012_lineam ientos_generales_uso_pruebas_antigenos_28092020.pdf.